Top compounds associated with response to AL365202.1


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.045 0.2
mRNA CIL41 CTRPv2 pan-cancer AAC 0.069 0.2
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC -0.17 0.2
mRNA fingolimod CTRPv2 pan-cancer AAC 0.048 0.2
mRNA TGX221 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.049 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA Imatinib CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV